February 09, 2022

More Guidance on Coverage of Over-the-Counter COVID-19 Test Kits

You've Reached Your
Free Article Limit This Month
Register for free to get unlimited access to all OnPractice content.
Register Now

Key Takeaways

  • Plans may take appropriate measures to prevent or limit fraud and abuse by, for example, by limiting coverage to reputable sellers and requiring receipts and certain attestations.

Following up on their earlier guidance the Departments of the Treasury, Labor, and Health and Human Services have issued an additional set of frequently asked questions and answers on the requirement to cover over-the-counter COVID-19 test kits. The new FAQ primarily offers further explanation of a safe harbor approach described in the earlier guidance. This safe harbor generally applies when coverage is made available without any up-front cost to enrollees through at least one direct-to-consumer shipping mechanism and one in-person mechanism:

  • An example of a direct-to-consumer mechanism is one that allows enrollees to order tests online or by telephone for home delivery. An example of an in-person mechanism is an arrangement involving in-network pharmacies that receive payment directly from the applicable plan or insurer. It is permissible for the direct-to-consumer mechanism to be met through retail pharmacies that provide an online or telephone option for home delivery.
  • A plan must provide appropriate information to take advantage of the safe harbor. For example, it should inform enrollees which tests will be covered through direct shipping and in-network pharmacy purchases, if they are limited. There is no requirement to cover test kits made by every manufacturer under the safe harbor, although plans must still cover all test kits under the general requirement (a plan may limit reimbursement outside of the safe harbor to $12 per kit).
  • Under the safe harbor, a plan must cover the cost of direct-to-consumer shipping in a manner consistent with how it covers other mail order products.
  • Under the safe harbor, a plan must provide adequate access to retail pharmacies or other in-person providers through, for example, locations that are adequate in number and geographic placement.

The over-the-counter coverage rules apply to tests that may be self-administered and self-read. Other tests, such as those that must be read in a lab, must be covered in accordance with applicable terms of the FFCRA and CARES Act.

Although the new guidance has an effective date of February 4, 2022, a plan will not be deemed out of compliance because of a shortage of supply in test kits. It still may limit coverage of non-direct purchases to $12 per kit during this time.

Plans may take appropriate measures to prevent or limit fraud and abuse by, for example, by limiting coverage to reputable sellers and requiring receipts and certain attestations. Requirements of this nature should be communicated to plan participants and may not impose conditions that result in undue delays in the provision of the test kits.

ALM expressly disclaims any express or implied warranty regarding the OnPractice Content, including any implied warranty that the OnPractice Content is accurate, has been corrected or is otherwise free from errors.

More From Ballard Spahr

New York Restricts Automated Decision Making in Employment

By Timothy Dickens Ballard Spahr August 29 , 2022

Businesses operating in New York City should be aware of a local law addressing the use of automated employment screening and decision-making tools coming into effect on January 1, 2023.

Status Update: Federal Contractor Vaccine Mandate Injunction Narrowed

By Lila A. Sevener Ballard Spahr August 29 , 2022

On August 26, 2022, the United States Court of Appeals for the Eleventh Circuit narrowed the nationwide injunction of Executive Order 14042, which requires federal contractors and employees who work on or in connection with a covered federal contract, or share a workplace with another employee who works on or in connection with such contracts, to be fully vaccinated against COVID-19.

Unions Cannot Force OSHA to Issue Permanent COVID Standard

By Shannon D. Farmer Ballard Spahr August 26 , 2022

On August 26, 2022, the U.S. Court of Appeals for the District of Columbia Circuit turned back efforts by a group of unions seeking to force the Occupational Safety and Health Administration (OSHA) to quickly issue a permanent rule establishing protections for healthcare workers from COVID-19.

More From Health Care

A Maze-Like Path and Laundry List Don't Provide Written Description

By Cecilia Choy, Ph.D. McDermott Will & Emery March 16 , 2023

The US Court of Appeals for the Federal Circuit affirmed a Patent Trial & Appeal Board (Board) decision that there was insufficient written description in the asserted priority applications to support a genus claim because of a lack of ipsis verbis disclosure and insufficient blaze marks.

This Week in 340B: March 7 - 13, 2023

By Emily Jane Cook McDermott Will & Emery March 15 , 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country.

Coverage of COVID-19 Vaccines and the End of the COVID-19 Emergency

By Jacob M. Mattinson McDermott Will & Emery March 15 , 2023

Since the Biden administration announced its intention to end the COVID-19 National Emergency (NE) and the COVID-19 Public Health Emergency (PHE) on May 11, 2023, a topic of great debate has been the requirement and the coverage of COVID-19 vaccines.

Featured Stories